n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, July 17th, 2015

The QualityStocks
Daily Stock List

graphic
graphic

SurePure, Inc. (SURP)

Greenbackers reported earlier on SurePure, Inc. (SURP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed SurePure, Inc. is a worldwide leader in liquid photopurification - the green alternative to pasteurization and chemicals. Utilizing its patented 'Turbulator' technology, SurePure’s systems use UV-C light to purify microbiologically sensitive liquids. The design of SurePure’s technology is to deliver food-grade solutions. Furthermore, the Company’s technology can be harnessed to improve processing liquids such as water, brines and sugar syrup solutions, and animal blood plasma. SurePure is headquartered in New York, New York.

The Company’s technology offers greater microbiological efficacy than conventional UV systems. The technology is effective for clear and turbid liquids.  In addition, SurePure provides opportunities for the development of innovative and differentiated products with desired consumer benefits, guaranteed food safety, as well as sound commercial benefits.

Its liquid photopurification technology purifies the above-mentioned turbid liquids. These include milk, beer, fruit juice, wine, carbonated beverages and an assortment of industrial applications. SurePure’s patented technology uses a specific band of ultraviolet light to provide a green alternative to heat and chemicals in the purification of turbid liquids.

In August 2014, SurePure announced that its main operating subsidiary, SurePure Operations AG, entered into an agreement for the sale of several SurePure photo-purification units to a major producer of high quality protein ingredients for manufacturers and complete products for end users. 

This past May, SurePure announced that SurePure Operations AG also entered into an agreement for the sale of a number of SurePure photo-purification units to a major producer of high quality protein ingredients for manufacturers and complete products for end users.  The customer is United States-based and operates in the animal nutrition industry.

Mr. Guy Kebble, Chief Executive Officer of SurePure, stated, "We are extremely pleased to report the successful commissioning of our technology by a U.S. customer with very high standards and a global reputation. This achievement is our largest installation to date and demonstrates both the commercial value of our patented photo-purification technology and the dedication of the SurePure team. We look forward to the continued application of our technology in this sector."

SurePure, Inc. (SURP), closed Friday's trading session at $0.15, even for the day, on 30,000 volume with 1 trade. The average volume for the last 60 days is 18,143 and the stock's 52-week low/high is $0.039/$0.40.

Cocrystal Pharma, Inc. (COCP)

Microcapmillionaires and PennyStocks Forever reported earlier on Cocrystal Pharma, Inc. (COCP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bothell, Washington-based Cocrystal Pharma, Inc. is a biotechnology company developing novel antiviral therapeutics for human diseases. It merged in 2014 with Biozone Pharmaceuticals, Inc. Cocrystal Pharma announced in November 2014 the closing of its merger with RFS Pharma, LLC. RFS Pharma is a privately-owned biotechnology company founded by renowned drug developer, Dr. Raymond Schinazi. Cocrystal Pharma’s shares trade on the OTC Bulletin Board.

The Company has earlier received strategic investments from Teva Pharmaceuticals, OPKO Health (OPK), and The Frost Group. OPKO Health and The Frost Group together own roughly 48 percent of Cocrystal Pharma. Cocrystal Pharma has five therapeutic programs targeting the Hepatitis C Virus (HCV), Influenza Virus, Dengue Virus, the Norovirus, and others. It has identified a picomolar inhibitor of NS5a, another essential viral replication protein.

Cocrystal Pharma focuses on the discovery and development of novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. It employs inventive technologies and Nobel Prize winning expertise to create first- and best-in-class antivirals. The design of these technologies and its market-focused approach to drug discovery are to efficiently deliver small molecule therapeutics that are safe, effective, as well as convenient to administer. 

The Company is targeting two Hepatitis C replication enzymes with its Polymerase program at lead optimization stage and its Helicase program at lead identification stage. Its Influenza, Dengue, and Norovirus programs are targeting unmet multi-billion dollar market opportunities with first-in-class antivirals. Cocrystal Pharma has developed what it believes to be the first high-throughput screening technology for inhibitors of a key essential Ebola virus gene product. It utilized its core platform technology to develop the in vitro test.

The Company’s Hepatitis C program continued to make progress in Q2 of 2014. It has chosen CDI-244 for development as a treatment for patients with Hepatitis C (HCV). Cocrystal plans regulatory filings to start clinical trials of CDI-244 this year. Company scientists have made excellent progress discovering potent inhibitors of the influenza endonuclease, an enzyme that is essential for viral genome replication.

Cocrystal Pharma is developing drug candidates specifically designed to be effective against all strains of the influenza virus and to have a high barrier to resistance. Selection of a lead compound for clinical development is planned to take place this year. Regulatory filings to commence clinical studies for influenza are planned for December 2015.

This week, Cocrystal Pharma announced the appointment of Mr. Walt Addison Linscott, Esq. as General Counsel and Corporate Secretary. Most recently, Mr. Linscott served as Global Strategic Legal Advisor for Thompson Hine, LLP. He provided strategic legal advice and business guidance to senior management and Board of Directors of multinational companies focused on the development of consumer products and human health products in complex emerging markets, the U.S. and the EU.

Cocrystal Pharma, Inc. (COCP), closed Friday's trading session at $1.00, up 6.38%, on 709,435 volume with 165 trades. The average volume for the last 60 days is 444,764 and the stock's 52-week low/high is $0.252/$1.53.

SolarWindow Technologies, Inc. (WNDW)

SmallCapVoice reported on SolarWindow Technologies, Inc. (WNDW), and we choose to report on the Company as well, here at the QualityStocks Daily Newsletter.

Columbia, Maryland-based SolarWindow Technologies, Inc. is a developer of next generation electricity-generating SolarWindow™ coatings. The Company was previously known as New Energy Technologies, Inc. It changed its corporate name to SolarWindow Technologies, Inc. this past March. The mission of SolarWindow Technologies has been to create SolarWindow™ products that generate substantial amounts of clean electricity, financially reward its customers, and benefit the environment. The Company lists on the OTCQB.

SolarWindow™ systems can be installed on the readily-available sizeable window glass surfaces on tall towers and skyscrapers. SolarWindow™ can be applied to all four sides of tall towers, producing electricity using natural, shaded, and artificial light. SolarWindow™ coatings generate electricity on see-through glass and flexible plastics with colored tints popular to skyscraper glass. SolarWindow™ uses organic materials that are dissolved into liquid, best for low-cost high-output manufacturing. SolarWindow™ is the subject of a patent pending technology.

Fundamentally, the Company’s SolarWindow™ products are undergoing development to be installed on all four sides of a skyscraper. This turns the entire building into a power generator. Commercial buildings account for 35 percent of all electricity consumed. Consequently, the Company believes this market opportunity is particularly significant.

SolarWindow Technologies announced this past April that engineers and research scientists at the University of North Carolina Charlotte Energy Production and Infrastructure Center (UNCC-EPIC) independently reviewed and validated the Company’s SolarWindow™ proprietary Power Production and Financial Model. This Model calculates a financial payback of under one year for the Company’s transparent electricity-generating SolarWindow™ technology. To produce the equivalent amount of power with conventional solar systems would require a minimum of 5-11 years for payback and a minimum 10-12 acres of valuable urban land.

Yesterday, SolarWindow Technologies announced that it will host its first-ever webcast called “SolarWindow: Power Reinvented”. The event will further demonstrate the Company’s dedication to bringing SolarWindow™ products to the marketplace. During the webcast, planned for the middle of August (with an exact date to be announced), SolarWindow Technologies plans to present the current state of SolarWindow™ product development; the evolution of SolarWindow™ research, performance, and technological advancements; and commercialization plans for bringing SolarWindow™ products to market.

SolarWindow Technologies, Inc. (WNDW), closed Friday's trading session at $2.08, up 1.46%, on 51,835 volume with 78 trades. The average volume for the last 60 days is 37,621 and the stock's 52-week low/high is $1.10/$2.48.

Midwest Energy Emissions Corp. (MEEC)

Wall Street Resources, Greenbackers and NBT Equities Research reported recently on Midwest Energy Emissions Corp. (MEEC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Midwest Energy Emissions Corp. develops and utilizes patented and proprietary technologies to remove mercury from coal-power plant emissions. It concentrates on the delivery of mercury capture technologies to power plants and other industrial coal-burning units in North America, Europe, and Asia. Midwest Energy Emissions is headquartered in Worthington, Ohio. The Company’s shares trade on the OTC Markets’ OTCQB.

The U.S. Environmental Protection Agency's (EPA) Mercury and Air Toxic Standards (MATS) rule requires that all coal- and oil-fired power plants in the U.S., larger than 25 mega-watts, must remove roughly 90 percent of mercury from their emissions. 

Midwest Energy Emissions employs patented technology that has been shown to attain mercury removal levels compliant with MATS at a considerably lower cost and with less operational impact than presently used methods. This is while preserving the ability for customers to recycle and sell fly-ash for beneficial use.

The Company’s proprietary SEA™ (Sorbent Enhancement Additive) technology delivers a flexible, tunable solution. It allows the global coal-power industry to easily comply with new, highly restrictive regulations on mercury air emissions. The SEA™ approach to mercury capture is exactly tailored for each application to complement a customer’s fuel type and boiler configuration for best results.

The Company’s high-grade sorbent enhancement additive is injected into the boiler in minimal amounts. It works together with proprietary sorbent products to ensure maximum mercury capture with premier economics versus normal mercury removal techniques in use today. This tailored approach substantially reduces the impact of mercury capture on balance-of-plant systems and operations.

Recently, Midwest Energy Emissions announced that the Energy & Environmental Research Center Foundation (EERCF) was awarded two new patents for emissions control. The two newest issued patents are U.S. Patent 9,011,805 issued on April 21, 2015, and Europe Patent # 1 931 449 issued on March 25, 2015. The Company now has 21 patents under its exclusive patent-licensing agreement with the EERCF, with an additional 8 patents pending, across key international markets in the U.S., Canada, Europe, and China.

Midwest Energy Emissions also announced the full commercialization of an essential product offering for customers that is offered as part of its patented SEA Technology for mercury air emissions control. The Company now has a fully commercialized product for high SO3 environments, with co-benefits of improved particulate control and acid-gas mitigation, important for proper system management and regulated emissions.

Midwest Energy Emissions has 15 electric generating units (EGUs) under contract for MATS compliance. Two EGUs have been operational since 2011. Another three injection systems were installed in April.

Midwest Energy Emissions Corp. (MEEC), closed Friday's trading session at $0.45, up 4.65%, on 23,964 volume with 4 trades. The average volume for the last 60 days is 62,575 and the stock's 52-week low/high is $0.21/$1.25.

Alliance BioEnergy Plus, Inc. (ALLM)

Stocks That Move reported on Alliance BioEnergy Plus, Inc. (ALLM), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Alliance BioEnergy Plus, Inc. focuses on "Green" energy and renewable technologies. Its subsidiaries concentrate on emerging technologies in the renewable energy, bio-fuels, and new technologies sectors. Alliance BioEnergy Plus operates two subsidiaries: AMG Renewables, LLC and Carbolosic Research, LLC. Through these subsidiaries it holds the exclusive worldwide license to proprietary intellectual property (IP), in the form of Patents and Patents Pending in the biofuels and fine chemicals industries. Alliance BioEnergy Plus is based in West Palm Beach, Florida.

AMG Renewables commercializes the Company controlled IP. Carbolosic Research creates new IP through exploring new pathways, new technologies, and emerging sciences. Alliance BioEnergy Plus owns a 50 percent interest in Carbolosic, LLC, and the exclusive rights to North America (including Canada, the U.S. and Mexico) and Africa. Carbolosic holds the exclusive, worldwide license to the patented mechanical/chemical technology, "CTS™" developed by the University of Central Florida.

The CTS technology can produce sugars, various fine chemicals, plastics, carbon fibers and other valuable products from almost any plant material, wood, or paper by product, fruit casings or bio waste.

Alliance BioEnergy Plus has completed the construction of its commercial scale CTS demonstration plant and research laboratories at its subsidiary Central Florida Institute of Science and Technology, Inc. (CFIST). CFIST (located in Longwood, Florida) is optimizing the commercial scale CTS line. The Company has several sub-licensees under MOU ready to convert to active sub-licenses upon the completion of optimization.

In May, Alliance BioEnergy Plus announced that via its subsidiary, AMG Energy Group, LLC, it signed its first licensing agreement for the territory of South Africa with Naldogen (Pty) Ltd. for an upfront fee of $25,000,000 plus royalties. It also negotiated a 24.5 percent ownership in Naldogen in exchange for a 24.5 percent ownership for Naldogen in a to be determined Company owned CTS plant in the U.S.  Naldogen Pty Ltd.’s plan is to change its name to Carbolosic Energy SA.

Last week, Alliance BioEnergy Plus announced that AMG Energy Group contracted with Process Engineering Associates, LLC to complete the Front-End Loading 1 and 2 (FEL 1 and FEL 2) engineering phases required for the construction of commercial CTS plants and to collect contracted license fees.  Under the direction of AMG Energy Group President Jim Brown and Company representative Gordon Lunt, Process Engineering Associates will begin the FEL 1 gated process promptly, moving onto the FEL 2 phase in roughly 6 weeks and completing both phases by mid-November 2015.

Alliance BioEnergy Plus, Inc. (ALLM), closed Friday's trading session at $0.51, up 18.33%, on 79,039 volume with 38 trades. The average volume for the last 60 days is 77,472 and the stock's 52-week low/high is $0.07/$1.67.

graphic

The QualityStocks
Company Corner

graphic
graphic

Wisdom Homes of America, Inc. (WOFA)

The QualityStocks Daily Newsletter would like to spotlight Wisdom Homes of America, Inc. (WOFA). Today, Wisdom Homes of America, Inc. closed trading at $0.0212, up 0.47%, on 159,750 volume with 7 trades. The stock’s average daily volume over the past 60 days is 93,810, and its 52-week low/high is $0.0211/$0.17.

Wisdom Homes of America, Inc. (WOFA) opens and operates manufactured home retail centers and is expanding into land/home packages. WOFA's revenue-generating growth model calls for expansion in the retail sector through the addition of related services and the opening of new retail centers in Texas, which sells 3x more manufactured homes than any other state. Revenue related services includes selling land/home packages, providing mortgage origination products and insurance services to homebuyers.

Push aside any stigma you have with mobile homes of the past; WOFA's manufactured homes are systematically engineered and designed with cutting-edge, computerized technology to deliver a superior level of exceptional quality, structure and affordability. Featuring wrap-around porches, vaulted ceilings, wood floors, rock fireplaces and 1,800-2,500-square foot floor plans, today's manufactured homes are second-to-none.

Another consumer appeal is cost; buying a new, aesthetically pleasing manufactured home is often less expensive than conventional housing. In fact, cost savings are up to 60% less per square foot than conventional site-built homes. While homebuyers can choose from many of WOFA's pre-existing floor plans, they can also customize the layout of their new home to fit their lifestyle and budget. Manufactured homes are customizable in arguably more ways than stick built homes. Additionally, each home meets strict HUD standards before it is ever shipped.

The manufactured housing industry is growing. In 2014 the sales of new manufactured homes exceeded $4.1 billion up from $3.8 billion in 2013. And that number is estimated to reach $4.5 billion in 2015. The industry growth is driven by demand for quality, affordable housing. WOFA also sees an adjacent market opportunity of approximately $10 billion annually in real estate acquisition, site preparations, ancillary services, and lending and lease communities for the manufactured housing industry that requires financing capital. By offering a superior product and adding new retail center locations throughout the State of Texas, WOFA is well-positioned to capture its share of the rapidly growing manufactured home market. Disclaimer

Wisdom Homes of America, Inc. Company Blog

Wisdom Homes of America, Inc. News:

Wisdom Homes Reports 2nd Quarter Revenue; Provides Update on Sherman Residential Development

Wisdom Homes Expands Tyler, Texas Retail Center; CEO Jim Pakulis Featured on TheStockRadio.com

Wisdom Homes of America Continues Its Expansion -- Signs Lease for New Retail Center

Fastfunds Financial Corp. (FFFC)

The QualityStocks Daily Newsletter would like to spotlight Fastfunds Financial Corp. (FFFC). Today, Fastfunds Financial Corp. closed trading at $0.0006, even for the day, on 4,341,666 volume with 12 trades. The stock’s average daily volume over the past 60 days is 10,348,759, and its 52-week low/high is $0.0005/$0.36.

Fastfunds Financial Corp. (FFFC) operates through two wholly owned subsidiaries, Cannabis Angel, Inc. and The 420 Development Corporation, to build a portfolio of revenue-generating companies that provide ancillary services to the burgeoning cannabis industry. The company also operates majority-owned subsidiary Financiera Moderna, Inc., which offers financial services to the underserved Hispanic community. FFFC's strategy to participate in the marijuana industry is through the development of four separate business verticals for the emerging U.S. cannabis industry.

Through its 49% stake in Cannabis Merchant Financial Solutions, Inc. (CMFS), FFFC entered the Financial Service business vertical. CMFS developed the Green Card and Tommy Chong Green Card, a reloadable stored value card with a rewards feature, and the Tommy Chong Frequent Buyers Card, which functions as a gift card or rewards card. FFFC is developing a national group of master resellers, distributors and sales representatives for these card products.

As the cannabis industry continues to develop, FFFC is partaking in Plant Botany, specifically the development of methods and technologies to significantly enhance plant growth and purity. Under an operating agreement with Sanidor Systems to create Pure Grow Systems, LLC, FFFC acquired a 49% interest in the subsidiary, which is dedicated to the healthy production and processing of raw materials used for medicinal or other health related purposes.

The cannabis industry is a cash-only business, which leaves companies vulnerable to criminal activities. FFFC plans to address this issue and enter the Security Services and Equipment sector through the acquisition of an existing, operational security company. FFFC owns a 70% stake in Ohio-based Brawnstone Security, Inc., a diversified security, training and investigations company. FFFC's research shows that operating margins for cannabis-related security services could exceed current billing levels by at least 100%.

FFFC's Cannabis Angel, Inc. ("CA") subsidiary will evaluate and provide corporate development services and early seed financing for worthwhile development-stage cannabis ventures. To date, CA has made investments in companies involved in the distribution of cannabis-related products and development of a social media website. It is important to note that all of FFFCs activities in the cannabis industry are ancillary, or pick and shovel, and are evaluated to insure compliance with all state and federal Laws. Disclaimer

Fastfunds Financial Corp. Company Blog

Fastfunds Financial Corp. News:

FastFunds Financial Corporation Subsidiary Pure Grow Systems, LLC Announces Product Label Approval

Fastfunds Financial Corporation Announces 20 Year Veteran In Managing High Profile Celebrities And Brands Named As Brand And Marketing Specialist For Tommy Chong Green Card

Pazoo, Inc., Through Its Wholly Owned Subsidiary CannabisKing Distribution, LLC, Signs Distribution Agreement with Pure Grow Systems™, a Subsidiary of FastFunds Financial Corporation To Distribute A State Of The Art Antimicrobial Sanitation System For Grow Facilities

Growblox Sciences, Inc. (GBLX)

The QualityStocks Daily Newsletter would like to spotlight Growblox Sciences, Inc. (GBLX). Today, Growblox Sciences, Inc. closed trading at $0.29, off by 3.33%, on 77,590 volume with 21 trades. The stock’s average daily volume over the past 60 days is 76,577, and its 52-week low/high is $0.151/$1.51.

Growblox Sciences, Inc. (GBLX), a biopharmaceutical research and development company, is focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies for various medical conditions. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

The company’s GrowBLOX technology suite includes the TissueBLOX, GrowBLOX, and CureBLOX equipment. Together, these components provide unparalleled control and monitoring of cannabis cultivation throughout the plant's life-cycle. These patent pending processes were designed to produce a safe and consistent cannabis product under cGMP guidelines. Utilizing a computer-regulated system that optimizes the nutrients, water, temperature, and gas levels, the GrowBLOX suite produces cannabis with more active ingredients per pound than traditional cultivation methods.

Also, based on an analysis of preclinical and clinical data from thousands of peer-reviewed studies, Growblox Sciences has identified the most effective profiles of cannabinoids and terpenes for the treatment of conditions within seven therapeutic categories. As a result of this extensive research and the analysis of the active ingredient profiles of 30,000 Cannabis strains in conjunction with a major testing lab, the company will be able to provide patients with natural cannabis strains containing the ideal ratios for treating specific diseases or symptoms.

Another significant advantage held by the company stems from an accelerated drug development program to finish in 3-5 years instead of the 15-20 years typically seen in traditional pharmaceutical development programs. Armed with an intellectual property strategy that takes full advantage of the design of the GrowBLOX technology suite and protects the valuable foundation laid, Growblox Sciences has positioned itself well for long-term success in the burgeoning cannabis space. Disclaimer

Growblox Sciences, Inc. Company Blog

Growblox Sciences, Inc. News:

GrowBLOX Receives Funding to Complete Construction of Nevada Cultivation Facility

GrowBLOX Announces Deployment of Commercial Units

Growblox Sciences, Inc. (GBLX) is “One to Watch”

MIT Holding (MITD)

The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.031, even with yesterday's close. The stock’s average daily volume over the past 60 days is 7,761, and its 52-week low/high is $0.03/$0.29.

MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.

In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.

MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer

MIT Holding Company Blog

MIT Holding News:

MIT Holding Achieves Positive Net Income From Operations in 2014

MIT Holding (MITD) Launches New Website with Investor Relations Suite

MIT Holding, Inc. Names Tommy J. Duncan as President

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0033, even with yesterday's close. The stock’s average daily volume over the past 60 days is 108,458, and its 52-week low/high is $0.0013/$0.008.

Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.

Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.

Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Signs License Agreement With NYG Holdings

Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited

Consorteum Holdings Launches New Mobile Results App for Popular Keno Game

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(CDEX)

2.

INO.com Market Report
(VLTC)

3.

RedChip
(AMEH)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251